Event wrap-up | SDSC-CONNECT: AI for Precision Medicine

By
Catherine Hugon
June 13, 2024
Share this post

The Swiss Data Science Center held its flagship conference SDSC-Connect, focusing on AI for Precision Medicine, at EPFL’s Rolex Learning Center, on 30 May 2024.

 

The event showcased how Switzerland’s strong foundation in research and clinical practice, coupled with a growing investment in AI, represents a unique environment to achieve significant impact in this field.

More than 170 researchers, innovators, domain experts, and data scientists gathered to discuss the transformative potential of AI for precision medicine.  

Thank you to all our amazing speakers and panellists for sharing their vision, insights and knowledge:

  • Prof. Martin Vetterli, President of EPFL
  • Prof. Susan Gasser, Director of ISREC and Member of the ETH Board
  • Prof. Andreas Wicki, USZ - Vice-Chairman of the Department of Medical Oncology and Hematology and Director of the Comprehensive Cancer Center Zurich (CCCZ)
  • Dr. Daniel Stekhoven, ETH Zurich, Director of Nexus Personalized Health Technologies
  • Prof. Catherine Jutzeler, ETH Zurich, Assistant Professor of Biomedical Data Science Department of Health Sciences and Technology Institute for Translational Medicine
  • Dr. Noushin Hadadi, Director of Data Science and Bioinformatics, Novigenix
  • Antoine Maison, Head of Digital Innovation, Tigen Pharma
  • Prof. Jean-Philippe Vert, Chief R&D Officer, Owkin

 

Their insightful talks and a panel discussion led by SDSC's Head of Biomedical, Dr. Nora Toussaint, touched on state-of-the-art advancements and challenges of data-driven precision medicine in Switzerland.

In a nutshell, AI for precision medicine holds great promises. Solid research data management, machine learning, and generative AI methods can help improve prediction and treatment of diseases, while showing remarkable potential to decrease mortality and cost. However, key challenges, like data quality and compliance, remain. Bringing clinicians, academics, and practitioners to work together is essential to overcoming the obstacles and realizing the full potential of AI in precision medicine.

We are deeply grateful to all participants for engaged discussions at EPFL’s Rolex Learning Center which made the event a resounding success!


SDSC-CONNECT is a series of conferences created by the Swiss Data Science Center addressing opportunities and challenges in data science applied indifferent user contexts.

About the SDSC:

The Swiss Data Science Center is a strategic initiative of the ETH domain with EPFL and ETH Zurich as founding partners. Its mission is to accelerate the adoption of data science and artificial intelligence within the Swiss academic community, the industrial sector, and public institutions. With a multidisciplinary team of data and computing specialists, it provides data science expertise and services addressing a wide range of needs and issues in various sectors with societal impact such as biomedical data science, energy, climate and environment, as well as digital administration and big data science. Thanks to its unique positioning at the crossroads of academia and business, it helps advance data-driven science, harnesses data science to create new business opportunities, and supports organizations in their digital journey.

 

For more information, please contact:


Catherine Hugon, Head of Executive Affairs

Catherine.hugon@epfl.ch

Uta Ünal, Head of Communications & Events

Uta.uenal@sdsc.ethz.ch

About the author

 Event wrap-up | SDSC-CONNECT: AI for Precision Medicine
Catherine Hugon
Head of Executive Affairs

Catherine joined the SDSC in late 2022. Prior to that, she carried out a variety of corporate communications management roles with multinationals in the consumer goods and digital technology fields. She also acted as a freelance consultant, advising organizations on their corporate communications strategy. She holds a Master of Arts degree from the University of Lausanne.

Share this post

More blog posts

April 22, 2024

The Promise of AI in Pharmaceutical Manufacturing

The Promise of AI in Pharmaceutical Manufacturing

Innovation in pharmaceutical manufacturing raises key questions: How will AI change our operations? What does this mean for the skills of our workforce? How will it reshape our collaborative efforts? And crucially, how can we fully leverage these changes?
Blog

More news

January 24, 2024

ADORE | A benchmark dataset in ecotoxicology to foster the adoption of machine learning

ADORE | A benchmark dataset in ecotoxicology to foster the adoption of machine learning

Applying machine learning to ecotoxicology could help reduce the number of animal tests, costs, and animals sacrificed while preserving the accuracy of the in vivo tests.
Blog
December 15, 2020

DeepEphys | Identifying biomarkers of Parkinson's disease with pluripotent stem cells

DeepEphys | Identifying biomarkers of Parkinson's disease with pluripotent stem cells

Parkinson’s disease is a severe neurodegenerative disorder that affects an increasing number of people in the world. Understanding the underlying mechanisms and the neuronal basis of this disease is a key step in the endeavor to develop new therapies.
Blog

Contact us

Let’s talk Data Science

Do you need our services or expertise?
Contact us for your next Data Science project!